Biologics Spark Market Interest In The Nasal Polyposis Treatment Space

Otolaryngology

Miracor Medical’s Picso Pivotal Study; Medtroni...

FDA Approved IDE for Picso® Pivotal Study of Miracor Medical On August 23, 2022, Miracor Medical SA, a provider of innovative solutions for the treatment of severe cardiac diseases, announced that ...

Sep 01, 2022

pharma news and updates for AstraZeneca, AbbVie, Sandoz, Incyte, Venatorx, and Bayer
AstraZeneca and Merck’s Lynparza; Venatorx’s cefepime-taniborbactam; AbbVie’s Qulipta; AstraZeneca’s IL-5 inhibitor Fasenra; Sandoz Acquires Coalesce; Incyte’s Opxelura; Bayer’s Nubeqa; NICE Rejects Keytruda Plus Chemotherapy

FDA Clears AstraZeneca and Merck’s Lynparza as an Adjuvant Breast Cancer Therapy The FDA approved the AstraZeneca and Merck drug for a specific group of patients with high-risk early breast cancer after chemotherapy treatment, either before or after surgery. Lynparza cements its position as the best-selling PARP...

Find More
medtech-news-updtes-updates-for-syntellix-bausch-lomb-movair-cochlear-laborie
Bausch + Lomb’s LuxSmart Intraocular Lenses; Movair’s Luisa Life Supporting Ventilator; Cochlear’s Nucleus and Baha Systems; Laborie Acquires Pelvalon; Know Labs’s SARS-CoV-2 Research; Syntellix’s MAGNEZIX;

Syntellix obtains product approval for India On October 07, 2021, Syntellix obtained the license to bring five different product families of its revolutionary bioabsorbable magnesium-based implants to market from India's Central Drugs Standard Control Organisation (CDSCO) for the Indian market. With this approva...

Find More
hearing-loss-treatment-market
Analysing the Treatment Approaches in the Hearing Loss Market and Key Companies in the Domain

Hearing Loss is a severe condition that has a multifaceted impact on the individual’s growth and development. It can lead to isolation and loneliness and can also significantly reduce the quality of life. As per the WHO, nearly 430 million people (representing over 5% of the world’s population) require rehabilitati...

Find More

More Views & Analysis

medtech-happenings-for-neurolief-paige-bionaut-retina-medtronic
RETINA-AI Health declares positive results; Medtronic’s Hugo robotic-assisted surgery system; Boston Scientific acquires Devoro Medical; Paige obtains first-ever FDA approval

RETINA-AI Health, Inc. declares positive pivotal study results for the RETINA-AI Galaxy™ autonomous Diabetic Retinopathy screening device On September 20, 2021, RETINA-AI Health, Inc. announced optimistic results from the pivotal study of the RETINA-AI Galaxy™, a multi-device compatible autonomous ...

Find More

Latest-pharma-happenings-for-hepion-nimbus-regeneron-bicycle-therapeutics
Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regeneron to support ISA Pharma

Hepion Pharma's NASH drug is set for Phase 2b after clearing the safety bar Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic drugs for the liver disease treatment arising from non-alcoholic steatohepatitis (NASH), declaring positive topline results from...

Find More

Sinusitis-Disease-Overview-Signs-and-Treatments
Sinusitis: Something More Troublesome Than Just Cold

Cold can make anyone cheerless and miserable, however, having Sinusitis is another story. Also known as rhinosinusitis, Sinusitis makes a person suffer from a stuffy nose, blocked nasal passages, congestion, throbbing pain in eyes, forehead, and cheeks, exhaustion and excess mucous leading to full-blown cold for we...

Find More

Thrombocytopenia drugs market | Drug-Induced Thrombocytopenia
Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. Thrombocytopenia pipeline possesses potential drugs in mid-stage d...

Find More

recent-pharma-biotech-news-updates-for-ikena-terns-ribometrix-hologic
Ikena bags $120M; Terns raises $87M for NASH; Ribometrix Genentech Collaboration; Hologic acquires Biotheranostics

Ikena secures USD 120 Million to advance a growing pipeline of cancer drugs Ikena Oncology has bagged USD 120 million to develop its expanding pipeline of cancer drugs. The Series B round begins as Ikena prepares to add a TEAD inhibitor to its roster of clinical programs and pushes a first-in-class KRAS asset th...

Find More

Raynaud's disease
Raynaud’s Disease -A debilitating condition

Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold or feeling stressed in some areas of the body like fingers and toes, blood can't reach to the epidermis (surface of the skin) and the affected areas turn wh...

Find More

Healthcare Performance Improvement provides proven methods for sustaining and building a culture of .....

Find More

AAV Vectors are the leading viral vectors for gene delivery to treat a variety of human diseases. Ad.....

Find More

The medical device (MedTech) industry has small and big companies operating in various segments such.....

Find More

Market intelligence (MI) is described as the information or the data derived by a company from the m.....

Find More

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Find More

Cystic fibrosis (CF) is a hereditary condition leading to chronic lung infections and eventually dec.....

Find More